Mark Bounthavong
Impact in
- Geriatrics and Gerontology top 1%
- Pharmaceutical Practices and Patient Outcomes
- Family Practice top 1%
- Medication Adherence and Compliance
Papers in
-
- Pharmaceutical Practices and Patient Outcomes 29
-
- Medication Adherence and Compliance 14
- Co-authors
- Taryn ErhardtAmanda M. MidboeJustina WuR GaleCaitlin M. ReardonLaura J. DamschroderJonathan H. WatanabeDonald Hsu
- Journals
- Journal of the American Pharmacists Association (11 papers)Value in Health (9 papers)PharmacoEconomics (3 papers)Journal of Evaluation in Clinical Practice (3 papers)Research in Social and Administrative Pharmacy (3 papers)
- Partner nations
- United StatesAustraliaCanada
In The Last Decade
Mark Bounthavong
83 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 133
- Geriatrics and Gerontology 362
- Family Practice 161
- Applied Microbiology and Biotechnology 46
- General Health Professions 512
- Anesthesiology and Pain Medicine 99
Countries citing papers authored by Mark Bounthavong
This map shows the geographic impact of Mark Bounthavong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Bounthavong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Bounthavong more than expected).
Fields of papers citing papers by Mark Bounthavong
This network shows the impact of papers produced by Mark Bounthavong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Bounthavong. The network helps show where Mark Bounthavong may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Bounthavong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 5 | |
| 8 | 2023 | 0 | |
| 9 | 2022 | 4 | |
| 10 | 2022 | 1 | |
| 11 | 2022 | 10 | |
| 12 | 2019 | 32 | |
| 13 | 2016 | 10 | |
| 14 | 2014 | 12 | |
| 15 | 2012 | 6 | |
| 16 | 2012 | 24 | |
| 17 | 2011 | 1 | |
| 18 | 2011 | 5 | |
| 19 | 2011 | 46 | |
| 20 | 2011 | 33 |
About Mark Bounthavong
Mark Bounthavong is a scholar working on Geriatrics and Gerontology, Family Practice, Applied Microbiology and Biotechnology, Public Health, Environmental and Occupational Health and Anesthesiology and Pain Medicine, having authored 94 papers that have together received 1.8k indexed citations. Recurring topics across this work include Pharmaceutical Practices and Patient Outcomes (29 papers), Opioid Use Disorder Treatment (20 papers), Medication Adherence and Compliance (14 papers), Health Systems, Economic Evaluations, Quality of Life (10 papers), Antimicrobial Resistance in Staphylococcus (8 papers), Health Policy Implementation Science (8 papers), Substance Abuse Treatment and Outcomes (7 papers) and Primary Care and Health Outcomes (7 papers). The work is most often cited by research in Geriatrics and Gerontology (362 citations), Family Practice (161 citations), Applied Microbiology and Biotechnology (46 citations), General Health Professions (512 citations) and Anesthesiology and Pain Medicine (99 citations). Mark Bounthavong has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include Taryn Erhardt, Amanda M. Midboe, Justina Wu, R Gale, Caitlin M. Reardon, Laura J. Damschroder, Jonathan H. Watanabe, Donald Hsu, Melissa L.D. Christopher and Anandi V. Law. Their work appears in journals such as Journal of the American Pharmacists Association, Value in Health, PharmacoEconomics, Journal of Evaluation in Clinical Practice and Research in Social and Administrative Pharmacy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.